He received his B.S. in Bioengineering from the University of California, Los Angeles, his Ph.D. in Biological Engineering from the Massachusetts Institute of Technology, and was an independent fellow at the Koch Institute for Integrative Cancer Research. His awards include the NIH Director’s Early Independence Award, Siebel Scholars award, and a Terri Brodeur Breast Cancer Foundation Fellowship. The Meyer lab focuses on combining experimental and computational techniques to reverse engineer cancer and innate immune signaling, with the goal of designing immune-and cancer-targeted therapies.